Physician profile
Rory D Trottier
NPI 1427002930
$2,487.14
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,098 · 2020: $176 · 2021: $159 · 2022: $54.71.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $1,831.50 | 2019-2020 | |
| Abbvie INC. | $496.55 | 2019-2021 | |
| Myovant Sciences INC. | $41.46 | 2022 | |
| Coloplast Corp | $34.34 | 2019 | |
| Coopersurgical, INC. | $28.99 | 2020 | |
| Minerva Surgical, INC | $24.80 | 2020 | |
| Olympus America INC. | $16.25 | 2021 | |
| Astellas Pharma US INC | $13.25 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rory Trottier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.